Basel Medical (BMGL) Receivables (2023 - 2025)

Basel Medical's Receivables history runs 3 years deep, the most recent figure standing at $7.4 million for Q2 2025.

• In Q2 2025, Receivables rose 430.13% year-over-year to $7.4 million; the TTM figure through Jun 2025 stood at $7.4 million (up 430.13% YoY), while the FY2025 annual figure was $7.4 million, up 430.13% from the prior year.
• Receivables came in at $7.4 million for Q2 2025 at Basel Medical, up from -$2.3 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $7.4 million in Q2 2025 to a low of -$2.3 million in Q4 2024.
• A 3-year average of $1.3 million and a median of $114169.4 in 2023 frame the typical range for Receivables.
• Across the five-year window, Receivables slumped 94.47% in 2024 and jumped 430.13% in 2025, its largest moves.
• Basel Medical's Receivables stood at -$1.2 million in 2023, then plunged by 94.47% to -$2.3 million in 2024, then surged by 425.98% to $7.4 million in 2025.
• According to Business Quant data, Receivables over the past three periods registered $7.4 million, -$2.3 million, and $1.4 million for Q2 2025, Q4 2024, and Q2 2024 respectively.

Peer Comparison